✦ LIBER ✦

The effect of combination treatment with gemcitabine and the EGFR-receptor tyrosine kinase inhibitor iressa with photodynamic therapy in bladder cancer

✍ Scribed by C.H. Briggs; C.D. Betts; K.J. O'Flynn; J.V. Moore; N.W. Clarke

Book ID: 118644328
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 200 KB
Volume: 2
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(03)80175-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The radiosensitising effects of Iressa (

The radiosensitising effects of Iressa (ZD 1839), an EGFR tyrosine kinase inhibitor, on related bladder cancer cell lines in vitro

✍ S. Maddineni; V. Sangar; J. Hendry; C. Betts; K. O'Flynn; N. Clarke 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Preclinical rationale for a combined tre

Preclinical rationale for a combined treatment with irinotecan and the epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) ZD1839 (Iressa) in irinotecan-refractory human colon cancer

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Epidermal growth factor receptor tyrosin

Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), ZD1839 (‘Iressa’), in combination with 5-fluorouracil (5-FU) and leucovorin (LV), in advanced colorectal cancer (ACRC)

✍ L. Hammond; J. Figueroa; L. Schwartzberg; L. Ochoa; M. Hidalgo; N. Olivo; G. Sch 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 346 KB

Anti-Angiogenic Activity of Selected Rec

Anti-Angiogenic Activity of Selected Receptor Tyrosine Kinase Inhibitors, PD166285 and PD173074: Implications for Combination Treatment with Photodynamic Therapy

✍ Charles J. Dimitroff; Wayne Klohs; Amarnath Sharma; Paula Pera; Denise Driscoll; 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 268 KB

ZD1839 (Iressa), a novel epidermal growt

ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression

✍ Neil G. Anderson; Tawhid Ahmad; Kai Chan; Richard Dobson; Nigel J. Bundred 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 192 KB 👁 1 views

Overexpression of the growth factor receptors EGFR and erbB2 occurs frequently in several human cancers and is associated with aggressive tumour behaviour and poor patient prognosis. We have investigated the effects of ZD1839 (Iressa), a novel EGFR tyrosine kinase inhibitor, on the growth, in vitro

Mutations in the epidermal growth factor

Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers

✍ Takayuki Fukui; Tetsuya Mitsudomi 📂 Article 📅 2008 🏛 Springer Japan 🌐 Japanese ⚖ 265 KB